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AbstrACt
Objectives To identify the shared priorities for future 
research of women affected by and clinicians involved with 
pessary use for the management of prolapse.
Design A priority setting project using a consensus 
method.
setting A James Lind Alliance Pessary use for prolapse 
Priority Setting Partnership (JLA Pessary PSP) conducted 
from May 2016 to September 2017 in the UK.
Participants The PSP was run by a Steering Group 
of three women with experience of pessary use, three 
experienced clinicians involved with management of 
prolapse, two researchers with relevant experience, a JLA 
adviser and a PSP leader. Two surveys were conducted 
in 2016 and 2017. The first gathered questions about 
pessaries, and the second asked respondents to prioritise 
a list of questions. A final workshop was held on 8 
September 2017 involving 10 women and 13 clinician 
representatives with prolapse and pessary experience.
results A top 10 list of priorities for future research in 
pessary use for prolapse was agreed by consensus.
Conclusions Women with experience of pessary use 
and clinicians involved with prolapse management have 
worked together to determine shared priorities for future 
research. Aligning the top 10 results with existing research 
findings will highlight the gaps in current evidence and 
signpost future research to areas of priority. Effective 
dissemination of the results will enable research funding 
bodies to focus on gathering the evidence to answer the 
questions that matter most to those who will be affected.
IntrODuCtIOn
Pelvic organ prolapse is prevalent and costly 
and estimated to affect 30%–50% of all women 
who have had a vaginal delivery.1 2 Pessary 
use is widespread, and inexpensive but has a 
limited evidence base.3
Symptomatic prolapse is defined as a 
downward displacement of the pelvic organs 
(bladder, bowel or uterus) or vaginal apex 
from the normal anatomical position and is 
associated with feelings of vaginal heaviness 
or bulge.4 Additional symptoms may include 
difficulties with emptying the bladder and 
bowel, leakage of urine and faeces and prob-
lems with sexual activity.
Treatment options for women with 
prolapse include pelvic floor muscle exer-
cises, a vaginal pessary device and surgery. 
A pessary is a silicone or plastic device of a 
supportive or space-occupying design that 
is positioned within the vagina to provide 
anatomical correction and support of the 
prolapsed compartment with the aims of 
reducing symptoms. A pessary is usually fitted 
in an outpatient clinic, left in situ for 4–6 
months and then removed and replaced by 
a healthcare professional. Some women are 
taught to self-manage their pessary removing 
and replacing it as required.
Vaginal devices for prolapse have been in 
use since the time of the Ancient Egyptians,5 
and published surveys suggest that currently 
up to 85% of gynaecologists use a pessary in 
the first-line management of prolapse,6–8 with 
70 000 National Health Service (NHS) pessary 
procedures recorded in NHS data 2015–2016 
(Sources: Information Services Division, NHS 
Scotland; HES data accessed 16 April 2017).
strengths and limitations of this study
 ► This is the first UK equal collaboration of women and 
clinicians with experience of prolapse and pessary 
use to achieve consensus on the priorities for future 
research.
 ► The James Lind Alliance uses a rigorous and trans-
parent method enhancing the confidence that fund-
ing bodies can have in the results.
 ► The use of an online survey as the main meth-
od for gathering questions for this Priority Setting 
Partnership may mean that not all groups of wom-
en with prolapse and pessary experience were 
accessed and that some groups may be under-rep-
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Despite the high prevalence of pessary use for prolapse 
there is limited evidence for their use, no UK-wide training 
for pessary fitting or management or information guide-
lines available for healthcare professionals or women with 
prolapse. The 2013 Cochrane review, ‘Pessaries (mechanical 
devices) for Pelvic Organ Prolapse in Women’ identified only 
one eligible randomised controlled trial with a maximum 
of seven trials being considered for the ongoing update9 
(Bugge 2018, personal communication).
Understanding the research priorities in pessary use 
for prolapse for those who will be affected will help build 
the evidence for the conservative treatment of prolapse. 
This report presents the results of the first collaboration 
of women with pessary experience and clinicians involved 
with pessary provision for prolapse in a James Lind Alli-
ance (JLA) Priority Setting Partnership (PSP). The top 10 
priorities are presented.
ObjeCtIve
We sought to determine the shared priorities for future 
research for women with experience of prolapse and 
pessaries, and healthcare professionals involved in the 
management of prolapse and fitting of pessaries.
MethOD
The JLA was established in 2004 to bring together health-
care professionals and service users affected by a condi-
tion in PSPs to determine the shared priorities for future 
research. Further information about the JLA method-
ology is available in the JLA guidebook.10
A Pessary use for prolapse PSP was established in May 
2016 bringing together for the first time women with 
experience of prolapse and pessary use and health-
care professionals with experience of the provision and 
fitting of pessaries. The Steering Group (SG) comprised 
three women with pessary experience, three clinicians 
experienced in managing prolapse with pessaries, two 
researchers and a pessary company representative; this 
group agreed the terms of reference and protocol for 
the PSP with guidance from the JLA adviser and project 
leader (KL). The JLA method for the Pessary use for 
prolapse PSP involved four stages (figure 1).
Patient and public involvement
Women with experience of prolapse and pessary use were 
central to this project from the inception with the under-
pinning principles of a JLA PSP including a requirement 
for the ‘balanced inclusion of patient, carer and clinician 
interests and perspectives.’10
At each stage of the process, women were equal part-
ners in the design and decisions including the SG, survey 
design and piloting, survey participation and the final 
workshop. All survey participants were able to indicate a 
desire for further involvement and for information about 
the results. A results summary will be sent to all those who 
have left contact details, and more broadly posted on the 
relevant websites and Facebook groups.
Gathering questions/uncertainties
Healthcare professionals, women with experience of 
prolapse and pessaries and researchers were targeted to 
gather their questions. A short survey was designed and 
piloted asking participants to submit up to three ques-
tions or uncertainties on any aspect of pessaries. Survey 
respondents were assured that there was no correct 
question and any uncertainty that they felt mattered to 
them was acceptable. The survey was launched online 
and promoted on social media to relevant organisations, 
professional bodies, health-related websites and forums 
for women with prolapse. Paper copies of the survey were 
distributed to four urogynaecology clinics in the UK for 
patients and healthcare professionals to complete. The 
JLA PSPs do not require ethical approval for distribution 
of surveys but local R&D approval was gained for each 
site. Relevant conferences and professional meetings 
were also targeted and attendees asked to access the 
survey online. A total of 210 completed responses were 
received with comparable representation from women 
and HCPs (table 1). Questions (n=669) were extracted 
from responses to the survey (n=530), online forums 
(n=59) and a review of the literature (n=80).
refining the questions and checking the evidence
The PSP SG refined and checked the 669 questions. No 
individual uncertainties were discarded, and a record of 
the origin of all the questions was kept.
Submitted questions not within the scope of the previ-
ously agreed PSP terms of reference including comments 
were collated and documented but not taken forward 
(n=51). Three SG pairs were formed of a woman with 
pessary experience and a clinician experienced in pessary 
provision. The pairs worked with the PSP project leader 
to combine and refine the remaining 618 submissions 
into 66 indicative questions which reflected the overall 
Figure 1 Flow chart of the James Lind Alliance (JLA) Priority 
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inference of the source questions. These were grouped 
into the following question categories: ‘fit’, ‘sex’, ‘choice’, 
‘who’, ‘risk’, ‘oestrogen’, ‘timing’, ‘care’ and ‘training’.
We applied the JLA definition of a treatment 
uncertainty10:
 ► No up-to-date, reliable systematic reviews of research 
evidence addressing the uncertainty about the effects 
of treatment exist.
 ► Up-to-date systematic reviews of research evidence 
show that uncertainty exists.
A systematic scoping review undertaken by the author 
(KL) with a search conducted from 2000 to 2016 (updated 
2018) identified several trials relevant to the submitted 
questions which were shared with the SG but it was agreed 
that none of the gathered questions had been answered 
sufficiently by existing research and that all the ques-
tions submitted to the Pessary use for prolapse PSP were 
genuine uncertainties.3 11–16
Prioritising/ranking the questions
A prioritising survey was launched in June 2017 asking 
healthcare professionals and women with experience of 
prolapse to choose their personal top 10 questions from 
the 66 questions presented in the survey. The survey was 
distributed and promoted using the same methods as 
the first, with seven urogynaecology clinics for the paper 
surveys. Additionally, the project leader (KL) presented 
the survey to an Asian Women’s Support Group meeting 
to identify the group’s priorities. Two hundred and seven-
ty-eight responses were received (table 2). The number of 
times each question occurred in respondents’ top 10 was 
counted. The questions were then ranked on the basis of 
that count to show the order of priority of the 66 ques-
tions and the SG then agreed the top 25 questions to go 
forward to the final workshop.
Choosing the top 10 priorities by consensus
A final consensus workshop day was held on 8 September 
2017 involving 23 participants purposively selected with 
small group discussions being facilitated by three JLA 
advisers. The participants included a general practitioner 
(GP), specialist urogynaecology clinicians with a varied 
level of pessary fitting experience, specialist pelvic health 
physiotherapists and women within an age range of 30 to 
over 80 years with a wide variety of personal experience 
of pessary use for prolapse. There were 10 women and 
13 healthcare professionals. In advance of the final work-
shop the participants were sent the top 25 questions from 
the prioritising survey with no indication of the priority 
order, and asked to consider their top and bottom three 
questions for discussion on the day.
The JLA have adopted a modified nominal group 
technique (NGT) to achieve consensus in the final work-
shops. NGT has the advantage of being a well-established 
method, which works well in situations where there may be 
a concern about the strength of individual voices, where 
the topic may be contentious and where an outcome 




210 complete responses (166 online and 44 paper 
responses) from:
Women (n=71) 30–89 72% had experience 
of current or previous 
pessary use ranging 
from ‘less than 2 weeks’ 
to ‘over 5 years’
HCPs (n=87) 18–69 61% with experience of 
fitting pessaries
Those identifying 
as being both 
HCP and a woman 
with experience of 
prolapse (n=27)
18–89 74% had experience of 
fitting pessaries
44% had used a 
pessary for ranging 
from ‘2 weeks to 6 










HCP, healthcare professional. 




278 completed responses (255 online and 23 paper 
responses) from:
Women (n=114) 18—‘over 
80’
58% with experience 
of pessary use ranging 
from ‘less than 2 weeks’ 
to ‘over 5 years’
9% having refused a 
pessary




as being both HCP 
and a woman with 
experience of prolapse 
(n=26)
77% in the 
age range 
‘31–59’
96% with personal 
experience of pessary 
use
15% fitting pessaries
69% treating women 
with prolapse
Other (n=11) including 




Did not indicate 
demographics (n=52)
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needs to be decided within a short time frame. The use 
of the NGT and a purposively selected group reduced the 
risk of bias in the final outcome. No new questions are 
generated in the final workshop.
As illustrated in the flow chart (figure 2) a series of 
small group discussions and rankings were held. The 
interim rank orders from the small groupings were 
reverse scored each time to produce new rankings. The 
combined rankings from the small group sessions were 
then used to determine the ranked list of 25 questions 
that was then presented to the whole group for facilitated 
discussion to reach a final consensus on prioritisation of 
the top 10 questions.
results
The final top 10 priorities for future research in pessary 
use for prolapse indicate that sexual activity and psycho-
logical well-being are of key importance for healthcare 
professionals and women. The top 10 includes questions 
about self-management, pessary fitting and training, 
managing complications and the effectiveness of pessa-
ries (box 1).
DIsCussIOn
This PSP has brought together for the first time women and 
healthcare professionals with personal and professional 
experience of pessaries to ensure a collaborative and inclu-
sive approach in which all participants had equal voice. In 
order to maximise the chance that future research projects 
will provide evidence for pessary use and enable optimal 
care for women with prolapse, it is essential that the research 
questions concern the priorities of women and healthcare 
professionals who will be affected, and that women are 
partners at each stage of the research. This Pessary use 
for prolapse PSP has established the priority questions 
for future research which will be disseminated widely to 
ensure that research funding bodies are made aware of 
what matters most to those affected. The JLA collaboration 
with the National Institute of Health Research is key to this 
outcome.
This JLA Pessary use for prolapse PSP is part of a 
doctoral research project that will continue with the 
results of the PSP being mapped to the current liter-
ature to identify those priority areas where existing 
research has addressed the topic, and to reveal the 
information, research and evidence gaps for the top 10 
priorities.
The strengths of this project were:
 ► A unique collaboration of women and clinicians with 
experience of prolapse to achieve consensus on the 
priorities for future research.
 ► The use of a rigorous and transparent method with 
the JLA enhancing the validity of the process and 
increasing the likelihood of the future research 
agenda being targeted to those for whom it matters.
 ► The use of social media and an anonymous online 
survey minimised the risk of stigma and embarrass-
ment affecting participation.
There were limitations which should be acknowledged:
 ► The use of an online survey may have introduced a 
bias in favour of those women who use the internet 
and social media.
 ► Time and cost constraints reduced the number of 
clinical sites where women already receiving pessary 
care and their carers could have been targeted more 
effectively.
 ► Despite extensive attempts to ensure representation 
from GPs and women from ethnically diverse groups, 
there may be under-representation in these sectors.
All the unanswered questions generated by this PSP will 
be available on the JLA website and widely disseminated 
to research commissioners, public health bodies and 
research funders.
Figure 2 James Lind Alliance (JLA) Pessary Priority Setting 
Partnership (PSP) final workshop flow chart.
box 1 the final top 10 research priorities for pessary use 
for prolapse
1. How might a pessary affect sexual activity?
2. Do pessaries have an effect on the psychological well-being of 
women?
3. What is important for a pessary self-management programme?
4. What are the risks and complications of pessary use for prolapse?
5. Are pessaries effective as a long-term treatment for prolapse?
6. What is the best way to assess what type and size of pessary to 
use?
7. What is the best way to minimise and treat vaginal discharge 
caused by pessaries?
8. Does pessary use in prolapse have a positive impact on physical 
activity?
9. When should oestrogen cream be used with a pessary?
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